The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지

Effects of Repeated Nicotine Treatment on the Changes in Glutamate Receptor Subunits Levels in Mesocorticolimbic Dopamine Areas

  • Lee, Kuem-Ju (Graduate School of Biomedical Sciences, Korea University College of Medicine) ;
  • Kim, Dong-Hoon (Department of Pharmacology, Korea University College of Medicine) ;
  • Choi, Song-Hyen (Graduate School of Biomedical Sciences, Korea University College of Medicine) ;
  • Shin, You-Chan (Department of Pharmacology, Korea University College of Medicine) ;
  • Park, Sang-Ha (Department of Pharmacology, Korea University College of Medicine) ;
  • Moon, Bo-Hyun (Graduate School of Biomedical Sciences, Korea University College of Medicine) ;
  • Kang, Seung-Woo (Department of Pharmacology, Korea University College of Medicine) ;
  • Cho, Eu-Jin (Department of Pharmacology, Korea University College of Medicine) ;
  • Choi, Sang-Hyun (Department of Pharmacology, Korea University College of Medicine) ;
  • Chun, Boe-Gwun (Department of Pharmacology, Korea University College of Medicine) ;
  • Lee, Min-Soo (Department of Psychiatry, Korea University College of Medicine) ;
  • Shin, Kyung-Ho (Department of Pharmacology, Korea University College of Medicine)
  • Published : 2007.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Recent studies suggest that alterations in glutamate receptor subunit levels in mesocorticolimbic dopamine areas could account for neural adaptations in response to psychostimulant drugs. Although many drugs of abuse induce changes in ionotropic glutamate receptor subunits in mesocorticolimbic dopamine areas, the changes of ionotropic glutamate receptor subunits by repeated nicotine treatment in these areas are not known. To answer this question, we injected male Sprague-Dawley rats twice daily with nicotine (0.4 mg/kg) or saline (1 ml/kg) for 10 days. The immunoreactivity of NR1, GluR1, and GluR2 glutamate receptor subunits was examined $16{\sim}18 h$ after the last injection of saline or nicotine. Repeated nicotine treatment significantly increased NR1 levels in the ventral tegmental area (VTA). In addition, repeated nicotine treatment showed a tendency towards an increase in GluR1 levels in the VTA as well as in striatum. However, there was no significant change in glutamate receptor subunits in other areas including nucleus accumbens (NAc). These results demonstrate that repeated nicotine treatment increases NR1 levels in VTA similarly to other drugs of abuse, suggesting that elevated glutamate receptor subunits in the VTA, but not NAc may be involved in the excitation of mesocorticolimbic dopamine neurons by nicotine.

Keywords

References

  1. Benwell ME, Balfour DJ. The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br J Pharmacol 105: 849-856, 1992 https://doi.org/10.1111/j.1476-5381.1992.tb09067.x
  2. Benwell ME, Balfour DJ, Birrell CE. Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine. Br J Pharmacol 114: 454-460, 1995 https://doi.org/10.1111/j.1476-5381.1995.tb13248.x
  3. Berhow MT, Hiroi N, Nestler EJ. Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci 16: 4707 -4715, 1996 https://doi.org/10.1523/JNEUROSCI.16-15-04707.1996
  4. Boundy VA, Gold SJ, Messer CJ, Chen J, Son JH, Joh TH, Nestler EJ. Regulation of tyrosine hydroxylase promoter activity by chronic morphine in TH9.0-LacZ transgenic mice. J Neurosci 18: 9989-9995, 1998 https://doi.org/10.1523/JNEUROSCI.18-23-09989.1998
  5. Carlezon WA Jr, Boundy VA, Haile CN, Lane SB, Kalb RG, Neve RL, Nestler EJ. Sensitization to morphine induced by viral-mediated gene transfer. Science 277: 812-814, 1997 https://doi.org/10.1126/science.277.5327.812
  6. Carlezon WA Jr, Nestler EJ. Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse? Trends Neurosci 25: 610-615, 2002 https://doi.org/10.1016/S0166-2236(02)02289-0
  7. Chergui K, Charlety PJ, Akaoka H, Saunier CF, Brunet JL, Buda M, Svensson TH, Chovet G. Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. Eur J Neurosci 5: 137-144, 1993 https://doi.org/10.1111/j.1460-9568.1993.tb00479.x
  8. Churchill L, Swanson CJ, Urbina M, Kalivas PW. Repeated cocaine alters glutamate receptor subunit levels in the nucleus accumbens and ventral tegmental area of rats that develop behavioral sensitization. J Neurochem 72: 2397-2403, 1999 https://doi.org/10.1046/j.1471-4159.1999.0722397.x
  9. Corrigall WA, Coen KM, Adamson KL. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653: 278-284, 1994 https://doi.org/10.1016/0006-8993(94)90401-4
  10. Corrigall WA, Franklin KB, Coen KM, Clarke PB. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl) 107: 285-289, 1992 https://doi.org/10.1007/BF02245149
  11. Fagerstrom K. The epidemiology of smoking: health consequences and benefits of cessation. Drugs 62(Suppl 2): 1-9, 2002
  12. Fallon JH, Moore RY. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J Comp Neurol 180: 545-580, 1978 https://doi.org/10.1002/cne.901800310
  13. Ferrari R, Le Novere N, Picciotto MR, Changeux JP, Zoli M. Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections. Eur J Neurosci 15: 1810-1818, 2002 https://doi.org/10.1046/j.1460-9568.2001.02009.x
  14. Fisher JL, Pidoplichko VI, Dani JA. Nicotine modifies the activity of ventral tegmental area dopaminergic neurons and hippocampal GABAergic neurons. J Physiol Paris 92: 209-213, 1998 https://doi.org/10.1016/S0928-4257(98)80012-0
  15. Fitzgerald LW, Ortiz J, Hamedani AG, Nestler EJ. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J Neurosci 16: 274-282, 1996 https://doi.org/10.1523/JNEUROSCI.16-01-00274.1996
  16. Grenhoff J, Aston-Jones G, Svensson TH. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand 128: 351-358, 1986 https://doi.org/10.1111/j.1748-1716.1986.tb07988.x
  17. Grillner P, Svensson TH. Nicotine-induced excitation of midbrain dopamine neurons in vitro involves ionotropic glutamate receptor activation. Synapse 38: 1-9, 2000 https://doi.org/10.1002/1098-2396(200010)38:1<1::AID-SYN1>3.0.CO;2-A
  18. Hernandez LF, Segovia G, Mora F. Effects of activation of NMDA and AMPA glutamate receptors on the extracellular concentrations of dopamine, acetylcholine, and GABA in striatum of the awake rat: a microdialysis study. Neurochem Res 28: 1819- 1827, 2003 https://doi.org/10.1023/A:1026115607216
  19. Johnson SW, Seutin V, North RA. Burst firing in dopamine neurons induced by N-methyl-D-aspartate: role of electrogenic sodium pump. Science 258: 665-667, 1992 https://doi.org/10.1126/science.1329209
  20. Kaiser S, Wonnacott S. alpha-bungarotoxin-sensitive nicotinic receptors indirectly modulate [(3)HJdopamine release in rat striatal slices via glutamate release. Mol Pharmacol 58: 312- 318, 2000 https://doi.org/10.1124/mol.58.2.312
  21. Lane-Ladd SB, Pineda J, Boundy VA, Pfeuffer T, Krupinski J, Aghajanian GK, Nestler EJ. CREB (cAMP response elementbinding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci 17: 7890-7901, 1997 https://doi.org/10.1523/JNEUROSCI.17-20-07890.1997
  22. Lu W, Monteggia LM, Wolf ME. Withdrawal from repeated amphetamine administration reduces NMDAR1 expression in the rat substantia nigra, nucleus accumbens and medial prefrontal cortex. Eur J Neurosci 11: 3167-3177, 1999 https://doi.org/10.1046/j.1460-9568.1999.00736.x
  23. Manabe T, Aiba A, Yamada A, Ichise T, Sakagami H, Kondo H, Katsuki M. Regulation of long-term potentiation by H-Ras through NMDA receptor phosphorylation. J Neurosci 20: 2504- 2511, 2000 https://doi.org/10.1523/JNEUROSCI.20-07-02504.2000
  24. Marchi M, Risso F, Viola C, Cavazzani P, Raiteri M. Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals. J Neurochem 80: 1071-1078, 2002 https://doi.org/10.1046/j.0022-3042.2002.00805.x
  25. Neve RL, Howe JR, Hong S, Kalb RG. Introduction of the glutamate receptor subunit 1 into motor neurons in vitro and in vivo using a recombinant herpes simplex virus. Neuroscience 79: 435-447, 1997 https://doi.org/10.1016/S0306-4522(96)00645-8
  26. Nisell M, Nomikos GG, Hertel P, Panagis G, Svensson TH. Condition- independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat. Synapse 22: 369-381, 1996 https://doi.org/10.1002/(SICI)1098-2396(199604)22:4<369::AID-SYN8>3.0.CO;2-9
  27. Nisell M, Nomikos GG, Svensson TH. Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release. Pharmacol Toxicol 75: 348-352, 1994a https://doi.org/10.1111/j.1600-0773.1994.tb00373.x
  28. Nisell M, Nomikos GG, Svensson TH. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse 16: 36-44, 1994b https://doi.org/10.1002/syn.890160105
  29. Nisell M, Nomikos GG, Svensson TH. Nicotine dependence, midbrain dopamine systems and psychiatric disorders. Pharmacol Toxicol 76: 157-162, 1995 https://doi.org/10.1111/j.1600-0773.1995.tb00123.x
  30. Ortiz J, Fitzgerald LW, Charlton M, Lane S, Trevisan L, Guitart X, Shoemaker W, Duman RS, Nestler EJ. Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse 21: 289-298, 1995 https://doi.org/10.1002/syn.890210403
  31. Ortiz J, Fitzgerald LW, Lane S, Terwilliger R, Nestler EJ. Biochemical adaptations in the mesolimbic dopamine system in response to repeated stress. Neuropsychopharmacology 14: 443- 452, 1996 https://doi.org/10.1016/0893-133X(95)00152-4
  32. Overton P, Clark D. Iontophoretically administered drugs acting at the N-methyl-D-aspartate receptor modulate burst firing in A9 dopamine neurons in the rat. Synapse 10: 131-140, 1992 https://doi.org/10.1002/syn.890100208
  33. Priel A, Kolleker A, Ayalon G, Gillor M, Osten P, Stern-Bach Y. Stargazin reduces desensitization and slows deactivation of the AMPA-type glutamate receptors. J Neurosci 25: 2682-2686, 2005 https://doi.org/10.1523/JNEUROSCI.4834-04.2005
  34. Rasmussen K, Czachura JF. Nicotine withdrawal leads to increased firing rates of midbrain dopamine neurons. Neuroreport 7: 329- 332, 1995 https://doi.org/10.1097/00001756-199512290-00079
  35. Schilstrom B, Fagerquist MV, Zhang X, Hertel P, Panagis G, Nomikos GG, Svensson TH. Putative role of presynaptic alpha7* nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area. Synapse 38: 375-383, 2000 https://doi.org/10.1002/1098-2396(20001215)38:4<375::AID-SYN2>3.0.CO;2-Y
  36. Schilstrom B, Nomikos GG, Nisell M, Hertel P, Svensson TH. N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens. Neuroscience 82: 781-789, 1998a
  37. Schilstrom B, Svensson HM, Svensson TH, Nomikos GG. Nicotine and food induced dopamine release in the nucleus accumbens of the rat: putative role of alpha7 nicotinic receptors in the ventral tegmental area. Neuroscience 85: 1005-1009, 1998b https://doi.org/10.1016/S0306-4522(98)00114-6
  38. Shim I, Javaid JI, Wirtshafter D, Jang SY, Shin KH, Lee HJ, Chung YC, Chun BG. Nicotine-induced behavioral sensitization is associated with extracellular dopamine release and expression of c-Fos in the striatum and nucleus accumbens of the rat. Behav Brain Res 121: 137-147, 2001 https://doi.org/10.1016/S0166-4328(01)00161-9
  39. Shoaib M, Schindler CW, Goldberg SR, Pauly JR. Behavioural and biochemical adaptations to nicotine in rats: influence of MK801, an NMDA receptor antagonist. Psychopharmacology (Berl) 134: 121-130, 1997 https://doi.org/10.1007/s002130050433
  40. Suaud-Chagny MF, Chergui K, Chouvet G, Gonon F. Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area. Neuroscience 49: 63-72, 1992 https://doi.org/10.1016/0306-4522(92)90076-E
  41. Svensson TH, Mathe JM, Nomikos GG, Schilstrom B. Role of excitatory amino acids in the ventral tegmental area for central actions of non-competitive NMDA-receptor antagonists and nicotine. Amino Acids 14: 51-56, 1998 https://doi.org/10.1007/BF01345242
  42. Tajiri K, Emori K, Murata M, Tanaka K, Suzuki M, Uehara T, Sumiyoshi T, Ashby CR Jr, Kurachi M. Intracerebroventricular administration of NMDA-R1 antisense oligodeoxynucleotide significantly alters the activity of ventral tegmental area dopamine neurons: an electrophysiological study. Synapse 40: 275-281, 2001 https://doi.org/10.1002/syn.1050
  43. Terashima A, Cotton L, Dev KK, Meyer G, Zaman S, Duprat F, Henley JM, Collingridge GL, Isaac JT. Regulation of synaptic strength and AMPA receptor subunit composition by PICK1. J Neurosci 24: 5381-5390, 2004 https://doi.org/10.1523/JNEUROSCI.4378-03.2004
  44. Wang T, French ED. Electrophysiological evidence for the existence of NMDA and non-NMDA receptors on rat ventral tegmental dopamine neurons. Synapse 13: 270-277, 1993 https://doi.org/10.1002/syn.890130310
  45. Wolf DH, Numan S, Nestler EJ, Russell DS. Regulation of phospholipase Cgamma in the mesolimbic dopamine system by chronic morphine administration. J Neurochem 73: 1520-1528, 1999 https://doi.org/10.1046/j.1471-4159.1999.0731520.x